STAT3 and glioblastoma: In addition, STAT3 inhibitor S3I‐201 blocked the ability of CTRP8 to attenuate γH2AX protein levels upon TMZ treatment in patient GBM‐1/2 (Fig. 2E; Fig. S4B) and U87MG (Fig. 2F).